agilon health, inc.

For the period ended Nov 4, 2026. Filed Nov 4, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 4, 2026 · Filed Nov 4, 2026

Use the contents to explore the available documents and sections.

AGL$113.39-0.3%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.1 · In thousands, except per share data

In thousands, except per share data

	September 30,2026	December 31,2025
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$174,399	$173,713
Restricted cash and equivalents	71,980	—
Marketable securities	65,361	111,429
Receivables, net	1,017,120	673,793
Prepaid expenses and other current assets, net	70,929	137,762
Total current assets	1,399,789	1,096,697
Property, equipment, and capitalized software, net	24,038	25,417
Intangible assets, net	56,853	65,725
Other assets	84,841	83,451
Total assets	$1,565,521	$1,271,290
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Medical claims and related payables	$892,342	$929,770
Accounts payable and accrued expenses	325,956	127,477
Current debt	15,021	19,238
Total current liabilities	1,233,319	1,076,485
Long-term debt	15,512	15,750
Other liabilities	35,813	52,321
Total liabilities	1,284,644	1,144,556
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 16,795 and 16,589 shares issued and outstanding, respectively	168	166
Additional paid-in capital	2,157,392	2,103,976
Accumulated deficit	(1,876,540)	(1,978,324)
Accumulated other comprehensive income (loss)	(143)	916
Total stockholders’ equity (deficit)	280,877	126,734
Total liabilities and stockholders’ equity (deficit)	$1,565,521	$1,271,290

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.